Trump Effect: J&J Plans $55 Billion US Investment To „Accelerate American Innovation Engine”
The latest development in the US onshoring trend—spurred by President Donald Trump—is Johnson & Johnson’s announcement Friday morning of a massive $55 billion investment plan over the next four years to build manufacturing facilities and research infrastructure in the US.
J&J said the $55 billion in research, development, and technology investments represents a 25% increase compared to the previous four years and builds on its elevated US investment trends following Trump’s 2017 Tax Cuts and Jobs Act.
„Today’s announcements accelerate our nearly 140-year legacy as an American innovation engine tackling the world’s toughest healthcare challenges,” Joaquin Duato, Chairman and CEO of J&J, wrote in a press release.
Duato said, „Our increased U.S. investment begins with the groundbreaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but also manufacture cutting-edge medicines to treat patients in America and around the world.”
In addition to the 500,000 square foot, state-of-the-art biologics manufacturing facility in Wilson, North Carolina, which construction is already underway, J&J outlined its investment plans over Trump’s second term:
-
Three new advanced manufacturing facilities and the expansion of several existing sites across the Company’s Innovative Medicine and MedTech businesses that will create high-paying, high-technology jobs. The Company will share further information on these sites once available.
-
Significant investments in extensive R&D infrastructure aimed at developing lifesaving and life-changing treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.
-
Increased technology investments to help make drug discovery and development faster, support workforce training and enhance our business operations.
-
With its increased investment over the next four years, the Company’s US economic impact will build upon its already estimated more than $100 billion per year.
More color on the Wilson factory’s economic benefit to the American worker and surrounding community:
-
Expand our capacity to manufacture next-generation medicines for people living with cancer, immune-mediated and neurological diseases in America and around the world.
-
Support approximately 5,000 jobs during construction and create over 500 positions in North Carolina.
-
Create a $3 billion impact across the state in the first 10 years of operations.
In addition to J&J, in recent days or weeks:
-
Nvidia CEO Will Spend Hundreds Of Billions On US-Made Chips
-
Apple Goes MAGA: $500 Billion Investment Plan In America, 20,000 New Jobs
-
TSMC Intends to Expand Its Investment in the United States to $165 Billion to Power the Future of AI
-
Trump Unveils „Stargate” Project
The rise of US onshoring… This is America First.
Tyler Durden
Fri, 03/21/2025 – 10:40